![Richard Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Miller
Chief Executive Officer at
CORVUS PHARMACEUTICALS, INC.
Net worth: 35 M $ as of 29/06/2026
Profile
Dr. Richard A. Miller, MD, is a Chairman & Chief Executive Officer at Angel Pharmaceuticals Co., Ltd. and a Chairman, President & Chief Executive Officer at Corvus Pharmaceuticals, Inc. He is on the Board of Directors at BrainScope Co., Inc. Dr. Miller was previously employed as an Independent Director by Bolt Biotherapeutics, Inc., a Chairman, President & Chief Executive Officer by Graphea, Inc., a Chief Commercialization Officer & Associate Dean by The University of Texas at Austin, a President, Chief Executive Officer & Director by Principia Biopharma, Inc., a President, Chief Executive Officer & Director by Pharmacyclics, Inc., a Director & Vice President by IDEC Pharmaceuticals Corp., and an Advisor by VantagePoint Management, Inc. He also served on the board at CellPro, Inc. He received his undergraduate degree from Franklin & Marshall College and a doctorate degree from The State University of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/05/2026 | 2,331,742 ( 2.77% ) | 35 M $ | 29/06/2026 |
Richard Miller active positions
| Companies | Position | Start |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Chief Executive Officer | 31/01/2014 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases | Chief Executive Officer | 04/10/2020 |
BrainScope Co., Inc.
 BrainScope Co., Inc. Packaged SoftwareTechnology Services Operates as a medical neurotechnology company that develops AI-based, portable EEG platform solutions to objectively assess brain health at the point of care | Director/Board Member | 30/09/2023 |
Former positions of Richard Miller
| Companies | Position | End |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Director/Board Member | 11/06/2024 |
Graphea, Inc.
 Graphea, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical, engineering & life sciences | Chief Executive Officer | 30/09/2014 |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 30/11/2011 |
| PRINCIPIA BIOPHARMA INC. | Founder | 31/01/2011 |
| PHARMACYCLICS, INC. | Founder | 09/09/2008 |
Training of Richard Miller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
BrainScope Co., Inc.
BrainScope Co., Inc. Packaged SoftwareTechnology Services Operates as a medical neurotechnology company that develops AI-based, portable EEG platform solutions to objectively assess brain health at the point of care | Technology Services |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
VantagePoint Management, Inc.
 VantagePoint Management, Inc. Investment ManagersFinance VantagePoint invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
CellPro, Inc.
 CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphea, Inc.
Graphea, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical, engineering & life sciences | Commercial Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases | Health Technology |
- Stock Market
- Insiders
- Richard Miller
